|
[1]
|
Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology
Molecular Diversity,
2025
DOI:10.1007/s11030-024-11075-5
|
|
|
|
|
[2]
|
Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24neg cells in the locally advanced and metastatic breast cancer
Journal of Surgical Oncology,
2024
DOI:10.1002/jso.27716
|
|
|
|
|
[3]
|
Discovery, lead identification and exploration of potential oxadiazole derivatives in targeting STAT3 as anti-cancer agents
In Silico Pharmacology,
2024
DOI:10.1007/s40203-024-00261-w
|
|
|
|
|
[4]
|
Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24neg cells in the locally advanced and metastatic breast cancer
Journal of Surgical Oncology,
2024
DOI:10.1002/jso.27716
|
|
|
|
|
[5]
|
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Advances in Cancer Biology - Metastasis,
2023
DOI:10.1016/j.adcanc.2023.100089
|
|
|
|
|
[6]
|
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Advances in Cancer Biology - Metastasis,
2023
DOI:10.1016/j.adcanc.2023.100089
|
|
|
|
|
[7]
|
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Advances in Cancer Biology - Metastasis,
2023
DOI:10.1016/j.adcanc.2023.100089
|
|
|
|
|
[8]
|
Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer
Drug Resistance Updates,
2022
DOI:10.1016/j.drup.2022.100865
|
|
|
|
|
[9]
|
Targeted Nanomedicine for Breast Cancer Therapy
2022
DOI:10.1016/B978-0-12-824476-0.00006-1
|
|
|
|
|
[10]
|
Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and in vitro evaluation
Journal of Biomolecular Structure and Dynamics,
2022
DOI:10.1080/07391102.2021.1957717
|
|
|
|
|
[11]
|
ASC-J9 Blocks Cell Proliferation and Extracellular Matrix Production of Keloid Fibroblasts through Inhibiting STAT3 Signaling
International Journal of Molecular Sciences,
2022
DOI:10.3390/ijms23105549
|
|
|
|
|
[12]
|
ASC-J9 Blocks Cell Proliferation and Extracellular Matrix Production of Keloid Fibroblasts through Inhibiting STAT3 Signaling
International Journal of Molecular Sciences,
2022
DOI:10.3390/ijms23105549
|
|
|
|
|
[13]
|
Targeted Nanomedicine for Breast Cancer Therapy
2022
DOI:10.1016/B978-0-12-824476-0.00006-1
|
|
|
|
|
[14]
|
Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer
Drug Resistance Updates,
2022
DOI:10.1016/j.drup.2022.100865
|
|
|
|
|
[15]
|
Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and in vitro evaluation
Journal of Biomolecular Structure and Dynamics,
2021
DOI:10.1080/07391102.2021.1957717
|
|
|
|
|
[16]
|
Protective effects of eicosapentaenoic acid in adipocyte-breast cancer cell cross talk
The Journal of Nutritional Biochemistry,
2020
DOI:10.1016/j.jnutbio.2019.108244
|
|
|
|
|
[17]
|
A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception
Current Enzyme Inhibition,
2020
DOI:10.2174/1573408016666200316114209
|
|
|
|
|
[18]
|
Self-renewal signaling pathways in breast cancer stem cells
The International Journal of Biochemistry & Cell Biology,
2019
DOI:10.1016/j.biocel.2018.12.017
|
|
|
|
|
[19]
|
Influence of Resveratrol on the Immune Response
Nutrients,
2019
DOI:10.3390/nu11050946
|
|
|
|
|
[20]
|
Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway
Journal of Cellular Biochemistry,
2019
DOI:10.1002/jcb.27592
|
|
|
|
|
[21]
|
Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway
Journal of Cellular Biochemistry,
2019
DOI:10.1002/jcb.27592
|
|
|
|
|
[22]
|
Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad
Laboratory Animal Research,
2019
DOI:10.1186/s42826-019-0030-0
|
|
|
|
|
[23]
|
Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway
Journal of Cellular Biochemistry,
2019
DOI:10.1002/jcb.27592
|
|
|
|
|
[24]
|
Self-renewal signaling pathways in breast cancer stem cells
The International Journal of Biochemistry & Cell Biology,
2019
DOI:10.1016/j.biocel.2018.12.017
|
|
|
|
|
[25]
|
Influence of Resveratrol on the Immune Response
Nutrients,
2019
DOI:10.3390/nu11050946
|
|
|
|
|
[26]
|
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Molecular Therapy - Nucleic Acids,
2018
DOI:10.1016/j.omtn.2017.12.021
|
|
|
|
|
[27]
|
Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis
Medicine,
2018
DOI:10.1097/MD.0000000000009738
|
|
|
|
|
[28]
|
p38 Expression and Modulation of STAT3 Signaling in Oral Cancer
Pathology & Oncology Research,
2018
DOI:10.1007/s12253-018-0405-9
|
|
|
|
|
[29]
|
Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway
Oncotarget,
2018
DOI:10.18632/oncotarget.26294
|
|
|
|
|
[30]
|
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Molecular Therapy - Nucleic Acids,
2018
DOI:10.1016/j.omtn.2017.12.021
|
|
|
|
|
[31]
|
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Molecular Therapy - Nucleic Acids,
2018
DOI:10.1016/j.omtn.2017.12.021
|
|
|
|
|
[32]
|
Signal transducer and activator of transcription 3 downregulation in J774A.1 cell line as a model of M2 macrophages in tumor microenvironment
Journal of Cancer Research and Therapeutics,
2018
DOI:10.4103/0973-1482.187298
|
|
|
|
|
[33]
|
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets
The Journal of Steroid Biochemistry and Molecular Biology,
2017
DOI:10.1016/j.jsbmb.2016.07.006
|
|
|
|
|
[34]
|
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets
The Journal of Steroid Biochemistry and Molecular Biology,
2017
DOI:10.1016/j.jsbmb.2016.07.006
|
|
|
|
|
[35]
|
Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative
PLOS ONE,
2017
DOI:10.1371/journal.pone.0173121
|
|
|
|
|
[36]
|
Blueberry and malvidin inhibit cell cycle progression and induce mitochondrial-mediated apoptosis by abrogating the JAK/STAT-3 signalling pathway
Food and Chemical Toxicology,
2017
DOI:10.1016/j.fct.2017.09.054
|
|
|
|
|
[37]
|
Differentially expressed genes: OCT -4, SOX 2, STAT 3, CDH 1 and CDH 2, in cultured mesenchymal stem cells challenged with serum of women with endometriosis
Journal of Genetic Engineering and Biotechnology,
2017
DOI:10.1016/j.jgeb.2017.10.006
|
|
|
|
|
[38]
|
A preliminary immunohistochemical study of signal transducer and activator of transcription (STAT) proteins in primary oral malignant melanoma
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology,
2017
DOI:10.1016/j.oooo.2017.10.007
|
|
|
|
|
[39]
|
Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
Molecular Cancer,
2017
DOI:10.1186/s12943-017-0736-2
|
|
|
|